Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Montag, 28.05.2012Börsentäglich über 11.000 News von 416 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

BIOSANTE PHARMACEUTICALS INC

WKN: 905841  ISIN: US09065V2034  Ticker-Symbol: BSF 
Aktie:
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOSANTE PHARMACEUTICALS INC Chart 1 Jahr
1-Woche-Intraday-Chart
BIOSANTE PHARMACEUTICALS INC 1-Woche-Intraday-Chart

Aktuelle News zur BIOSANTE PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
18.05. 37
17.05. 14
10.05. 7
09.05. 19
09.05. 50
Shareholder Rights Law Firm Johnson & Weaver, LLP announces it is investigating whether certain officers and directors of Biosante Pharmaceuticals, Inc. (Nasdaq: BPAX)...
Mehr lesen zu:
Shareholder Rights Law Firm Johnson & Weaver, LLP Investigates Biosante Pharmaceuticals, Inc. for Securities Fraud
08.05. 40
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today reported on its financial results for the first quarter of 2012 and cash balance as of March 31, 2012. ...
Mehr lesen zu:
BioSante Pharmaceuticals Reports First Quarter Financial Results
03.05. 32
NEW YORK, NY -- (Marketwire) -- 05/03/12 -- Biotech stocks have continued to provide investors with strong gains in 2012. The iShares NASDAQ Biotechnology Index (IBB) is up nearly 20 percent year-to-date....
Mehr lesen zu:
Small Biotech Companies Look to Benefit From Shift to "First to File" Patent System / The Paragon Report Provides Stock Research on Biosante Pharmaceuticals and Advanced Cell Technology
23.04. 72
NEW YORK, NY -- (Marketwire) -- 04/23/12 -- Mergers and Acquisitions have been a hot topic in in the Biotechnology Industry recently. Pharmaceutical giants face an unprecedented number of patent expirations...
Mehr lesen zu:
Pharmaceutical Companies Look to Biotech Industry to Combat Losses From Expiring Patents / The Paragon Report Provides Stock Research on Biosante Pharmaceuticals Inc. and Exelixis, Inc.
11.04. 28
10.04. 30
04.04. 73
NEW YORK, April 4, 2012 /PRNewswire/ --Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of Illinois on behalf...
Mehr lesen zu:
Deadline Approaching: The Law Firm of Levi & Korsinsky Notifies Investors With Losses on Their Investment in BioSante Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position
04.04. 56
NEW ORLEANS, LA -- (Marketwire) -- 04/04/12 -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only...
Mehr lesen zu:
INVESTOR ALERT: Approximately 48 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Large Financial Interests of Important Deadline in Lawsuit Against BioSante Pharmaceuticals, Inc.
03.04. 57
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of Illinois on behalf of investors...
Mehr lesen zu:
Deadline Approaching: The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in BioSante Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position
29.03. 95
Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers ...
Mehr lesen zu:
BioSante Pharmaceuticals Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate Possible Breaches of Fiduciary Duty by the Officers and Directors of BioSante Pharmaceuticals, Inc.
20.03. 106
WASHINGTON (dpa-AFX) - BioSante Pharmaceuticals, Inc. (BPAX) announced that data from studies of the Pill-Plus 'triple component' oral contraceptive were presented on March 10, 2012 by Pantarhei...
Mehr lesen zu:
BioSante Announces Positive Pill-Plus Data Presentation
20.03. 4
20.03. 62
Improvements reported in sexual desire, arousal, responsiveness and activity BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced today that data...
Mehr lesen zu:
BioSante Pharmaceuticals Announces Positive Pill-Plus™ Data Presentation
19.03. 58
NEW YORK, NY -- (Marketwire) -- 03/19/12 -- Biotechnology stocks continue to be some of the strongest performers in the markets as favorable legislation out of Washington boosts the sector's reach....
Mehr lesen zu:
FAST Act to Modernize Approval Process -- Cardium and BioSante Poised to Benefit / The Paragon Report Provides Equity Research on Cardium Therapeutics & BioSante Pharmaceuticals
13.03. 90
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced financial results for the year ended December 31, 2011 and additional corporate highlights. ...
Mehr lesen zu:
BioSante Pharmaceuticals Reports Financial Results for 2011 and Corporate Highlights
13.03. 64
SAN DIEGO, CA -- (Marketwire) -- 03/13/12 -- The Shareholders Foundation, Inc. announces that a lawsuit has been filed in the U.S. District Court for the Northern District of Illinois on behalf of...
Mehr lesen zu:
BioSante Pharmaceuticals, Inc. (BPAX) Investor Lawsuit and Deadline on April 6 Announced by Shareholders Foundation
Seite: 1 2 3 4 Weiter>>
62 Nachrichten in den letzten 6 Monaten